Pentoxifylline: brief review and rationale for its possible use in the treatment of autism.
Gupta
S
S
University of California, Irvine, USA.
Rimland
B
B
Shilling
P D
PD
D000818:Animals; D001321:Autistic Disorder / Q000188:drug therapy* / Q000276:immunology; D001921:Brain / Q000098:blood supply; D002648:Child; D002986:Clinical Trials as Topic; D006801:Humans; D010431:Pentoxifylline / Q000009:adverse effects / Q000627:therapeutic use*; D010726:Phosphodiesterase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D012039:Regional Blood Flow / Q000187:drug effects; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors; D014665:Vasodilator Agents / Q000009:adverse effects / Q000627:therapeutic use*
D010726:Phosphodiesterase Inhibitors; D014409:Tumor Necrosis Factor-alpha; D014665:Vasodilator Agents; D010431:Pentoxifylline